Fig 1.
Participant flow through the study.
Table 1.
Baseline patient characteristics.
Fig 2.
Frequency of the most common EGFR mutations (n = 2,080).
Table 2.
EGFR mutation testing rates by year in 12,148 patients who underwent EGFR testing.
Table 3.
Frequency of first- and second-line treatment.
Fig 3.
Kaplan-Meier estimates of (A) TTNT, and (B) OS stratified by treatment group.
Fig 4.
Kaplan-Meier estimates of OS stratified by treatment group in patients diagnosed after May 2013.